Bayer

Last updated January 31, 2026

432

Innovation Areas

13,147

Inventors

104

Collaborations

Cryptographic patient eligibility authentication: BayerRecent Research Landscape

Unauthorized access to restricted treatments creates legal liability and patient safety risks. These innovations mitigate these risks through automated verification of clinical eligibility and identity credentials.

What technical problems is Bayer addressing in Cryptographic patient eligibility authentication?

Inaccurate molecular structural identification

(50)evidences

Inconsistent spatial or temporal registration between disparate data sources prevents accurate synthesis. Resolving this misalignment ensures high-fidelity predictive modeling and diagnostic reliability.

Inconsistent clinical data quality

(13)evidences

Disparate systems for fluid injection and radiation imaging lead to inconsistent patient safety protocols. Synchronizing these parameters prevents excessive physiological strain and radiation toxicity.

Inaccurate patient eligibility determination

(12)evidences

Fragmented and manual tracking of patient authorization leads to unauthorized data processing and legal non-compliance. Standardizing consent management ensures data integrity and legal validity across automated healthcare systems.